HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)
Not yet recruiting
- Conditions
- HIV Infection
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 220
- Registration Number
- NCT06913959
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)
Not yet recruiting
- Conditions
- Tuberculosis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 2000
- Registration Number
- NCT06893757
EBOla Post-Exposure Prophylaxis
Phase 3
Not yet recruiting
- Conditions
- Ebola Virus Disease
- Interventions
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 160
- Registration Number
- NCT06841614
- Locations
- 🇱🇷
National Public Health Institute of Liberia, Monrovia, Liberia
🇸🇱University of Sierra Leone College of Medicine and Allied Health Sciences, Freetown, Sierra Leone
🇨🇩National Institute for Biomedical Research (INRB), Kinshasa, Congo, The Democratic Republic of the
Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)
Not yet recruiting
- Conditions
- HIV Infection
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 800
- Registration Number
- NCT06842706
Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 238
- Registration Number
- NCT06821126
- Locations
- 🇫🇷
CHU Dijon Bourgogne - Centre d'Investigation Clinique 1432, Dijon, France
🇫🇷HCL - Hôpital de la Croix-Rousse - Service des Maladies Infectieuses et Tropicales, Lyon, France
🇫🇷APHP - Hôpital Cochin - Centre d'Investigation Clinique de Vaccinologie Cochin-Pasteur 1417, Paris, France
Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus
Not yet recruiting
- Conditions
- Japanese Encephalitis
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 4000
- Registration Number
- NCT06674837
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
Not Applicable
Not yet recruiting
- Conditions
- Anal CancerHPV Infection
- Interventions
- Procedure: High-resolution anoscopy
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 100
- Registration Number
- NCT06522256
- Locations
- 🇫🇷
Hôpital de la Croix Rousse - SMIT, Lyon, France
🇫🇷Hôpital Saint-Louis - SMIT, Paris, France
🇫🇷Hôpital Tenon - SMIT, Paris, France
Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity
Not Applicable
Not yet recruiting
- Conditions
- HIV Infections
- Interventions
- Other: Partner notification by a trained counsellor
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 400
- Registration Number
- NCT06419491
Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses
Phase 2
Not yet recruiting
- Conditions
- HBV CoinfectionHIV Infections
- Interventions
- Drug: TDF - 245mg or TAF -25mg associated to 3TC - 300mg or FTC - 200mg and a NNRTI or PI/r or INSTIDrug: Dual therapy with 3TC in combination with DTG or ritonavir-boosted Darunavir (rDVR)
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 140
- Registration Number
- NCT06338826
Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms
Not Applicable
Recruiting
- Conditions
- HIV Infections
- Interventions
- Biological: Blood sampling
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 451
- Registration Number
- NCT06302933
- Locations
- 🇨🇲
Hôpital de Jour - Hôpital Laquintinie de Douala, Douala, Cameroon
🇨🇲Unité Pédiatrique de Jour - Centre Mère et Enfant de la Fondation Chantal Biya, Yaounde, Cameroon
🇨🇲Service de Pédiatrie - Centre Hospitalier d'Essos, Yaoundé, Cameroon
© Copyright 2025. All Rights Reserved by MedPath